At the completion of this activity, the participant will be able to:
1.   Explain current guideline recommendations for the use of tenecteplase in acute ischemic stroke
2.  Describe the pharmacokinetic and pharmacodynamics differences between alteplase and tenecteplase
3.  Review comparative primary literature  of  tenecteplase versus alteplase for acute ischemic stroke
4.  Discuss the impact of implementing tenecteplase for acute ischemic stroke at other institutions

Session date: 
10/25/2023 - 12:00pm to 1:00pm EDT
AGH Board Room
1st Floor South Tower - Magovern Conference Center
Zoom Webinar:
Meeting ID: 986 7257 0454 - Passcode: 877628
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance

Please login or register to take this course.